Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Assets Average (2020 - 2025)

Pulse Biosciences has reported Assets Average over the past 6 years, most recently at $114.5 million for Q3 2025.

  • Quarterly results put Assets Average at $114.5 million for Q3 2025, up 71.58% from a year ago — trailing twelve months through Sep 2025 was $114.5 million (up 71.58% YoY), and the annual figure for FY2024 was $95.8 million, up 39.83%.
  • Assets Average for Q3 2025 was $114.5 million at Pulse Biosciences, down from $126.8 million in the prior quarter.
  • Over the last five years, Assets Average for PLSE hit a ceiling of $132.9 million in Q1 2025 and a floor of $40.1 million in Q2 2022.
  • Median Assets Average over the past 5 years was $70.4 million (2023), compared with a mean of $76.1 million.
  • Biggest five-year swings in Assets Average: tumbled 50.1% in 2022 and later skyrocketed 183.1% in 2025.
  • Pulse Biosciences' Assets Average stood at $63.2 million in 2021, then skyrocketed by 30.99% to $82.7 million in 2022, then dropped by 24.39% to $62.5 million in 2023, then skyrocketed by 80.26% to $112.8 million in 2024, then increased by 1.56% to $114.5 million in 2025.
  • The last three reported values for Assets Average were $114.5 million (Q3 2025), $126.8 million (Q2 2025), and $132.9 million (Q1 2025) per Business Quant data.